• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Communication, Education, and Radiological Programs (OCER) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetPercent
Oct 201085100
Nov 20108574
Dec 20108571
Jan 20118583
Feb 20118588
Mar 20118586
Apr 201185100
May 201185100
Jun 201185100
Jul 20118591
Aug 201185100
Sep 20118593

FY 2011 Overall: 89%

Number of OCER intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A9
Nov 2010N/A14
Dec 2010N/A5
Jan 2011N/A10
Feb 2011N/A14
Mar 2011N/A18
Apr 2011N/A11
May 2011N/A15
Jun 2011N/A7
Jul 2011N/A10
Aug 2011N/A5
Sep 2011N/A14

FY 2011 Total: 132

Total number of OCER intra- and inter-Office eConsults completed during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A9
Nov 2010N/A19
Dec 2010N/A7
Jan 2011N/A12
Feb 2011N/A16
Mar 2011N/A21
Apr 2011N/A11
May 2011N/A15
Jun 2011N/A7
Jul 2011N/A11
Aug 2011N/A5
Sep 2011N/A15

FY 2011 Total: 148

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.